Marcelo Cypel Selected Research

Brain Death (Brain Dead)

1/2022	Donation after circulatory death donors in high-risk recipients undergoing bilateral lung transplantation: An ISHLT database registry analysis.
1/2022	Donation after circulatory death and lung transplantation.
1/2021	Cell-free DNA in human ex vivo lung perfusate as a potential biomarker to predict the risk of primary graft dysfunction in lung transplantation.
1/2021	Transcriptomic investigation reveals donor-specific gene signatures in human lung transplants.
12/2019	Donation after circulatory death in lung transplantation-five-year follow-up from ISHLT Registry.
9/2019	Normothermic ex vivo lung perfusion: Does the indication impact organ utilization and patient outcomes after transplantation?
1/2016	Extracorporeal lung perfusion (ex-vivo lung perfusion).
10/2015	Expanding the lung donor pool: advancements and emerging pathways.
10/2015	International Society for Heart and Lung Transplantation Donation After Circulatory Death Registry Report.
10/2011	Extracorporeal lung perfusion.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marcelo Cypel Research Topics

Disease

22	Primary Graft Dysfunction 12/2022 - 08/2009
17	Death (Near-Death Experience) 12/2022 - 08/2009
13	Brain Death (Brain Dead) 01/2022 - 10/2009
11	Lung Injury 11/2022 - 11/2009
11	Lung Diseases (Lung Disease) 04/2022 - 06/2013
8	Reperfusion Injury 04/2022 - 11/2009
7	Neoplasms (Cancer) 10/2022 - 10/2009
7	Inflammation (Inflammations) 01/2022 - 10/2009
6	Acute Lung Injury 05/2021 - 01/2008
5	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 02/2022 - 02/2010
5	Infections 12/2020 - 05/2010
5	Respiratory Insufficiency (Respiratory Failure) 11/2020 - 02/2014
4	COVID-19 01/2022 - 10/2020
4	Necrosis 09/2021 - 01/2016
4	Wounds and Injuries (Trauma) 01/2021 - 11/2009
4	Heart Arrest (Cardiac Arrest) 01/2021 - 10/2015
4	Sepsis (Septicemia) 01/2020 - 08/2009
4	Pulmonary Edema 01/2018 - 04/2011
3	Hepatitis C 12/2022 - 01/2020
3	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 06/2016
3	Edema (Dropsy) 01/2020 - 12/2008
3	Bronchiolitis Obliterans Syndrome 01/2016 - 08/2009
2	Neoplasm Metastasis (Metastasis) 09/2021 - 02/2014
2	Cystic Fibrosis (Mucoviscidosis) 01/2020 - 10/2009
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 11/2015
2	Ischemia 03/2016 - 01/2008
2	Critical Illness (Critically Ill) 10/2015 - 10/2009
1	Lung Neoplasms (Lung Cancer) 10/2022
1	Pulmonary Hypertension 01/2022
1	Heart Failure 01/2022
1	Body Weight (Weight, Body) 11/2021
1	Colorectal Neoplasms (Colorectal Cancer) 09/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2021
1	Pain (Aches) 01/2021
1	Ventilator-Induced Lung Injury 12/2020
1	Coinfection 01/2020
1	Diabetes Mellitus 01/2020
1	Liver Diseases (Liver Disease) 01/2020
1	Viremia 12/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2019
1	Cytomegalovirus Infections (Inclusion Disease) 12/2019
1	Emphysema 12/2019
1	Blastomycosis 11/2019
1	Melanoma (Melanoma, Malignant) 05/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	Hemorrhage 12/2018
1	Pleural Effusion (Pleural Effusions) 01/2018

Drug/Important Bio-Agent (IBA)

12	dicarboxydine (DCD)IBA 01/2022 - 08/2009
12	Prostaglandins DIBA 01/2021 - 08/2009
4	Oxygen (Dioxygen)IBA 03/2022 - 04/2011
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2010
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2016
3	prostaglandin D3IBA 01/2021 - 03/2015
3	serum P-component (CIt)IBA 01/2020 - 01/2016
2	Interleukin-10 (Interleukin 10)IBA 12/2021 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2020
2	Anesthetics (Anesthetic Agents)IBA 01/2021 - 05/2017
2	Antiviral Agents (Antivirals)IBA 12/2020 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2020 - 12/2019
2	CytokinesIBA 10/2018 - 01/2018
2	HMGB ProteinsIBA 06/2017 - 01/2016
2	FibrinIBA 02/2010 - 11/2009
2	Thromboplastin (Tissue Factor)IBA 02/2010 - 01/2008
1	Nucleic AcidsIBA 12/2022
1	purineIBA 04/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2021
1	phytochlorinIBA 09/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2021
1	Carbon DioxideIBA 01/2021
1	Mitochondrial DNA (mtDNA)IBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	Macrophage Migration-Inhibitory FactorsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2020
1	glecaprevir and pibrentasvirIBA 01/2020
1	Ezetimibe (Zetia)FDA Link 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2019
1	7,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA 09/2019
1	Interleukin-2 (IL2)IBA 05/2019
1	Protein Kinases (Protein Kinase)IBA 10/2018

Therapy/Procedure

48	Lung Transplantation 04/2022 - 10/2009
28	Transplantation 11/2022 - 12/2008
18	Therapeutics 10/2022 - 02/2010
11	Extracorporeal Membrane Oxygenation 01/2022 - 10/2009
5	Drug Therapy (Chemotherapy) 01/2022 - 02/2014
4	Artificial Respiration (Mechanical Ventilation) 09/2021 - 11/2019
3	Length of Stay 12/2022 - 01/2018
3	Pneumonectomy (Lung Volume Reduction) 01/2022 - 01/2017
2	Precision Medicine 01/2021 - 12/2013
1	Radiofrequency Ablation 10/2022
1	Bronchoscopes 10/2022
1	Endarterectomy (Thromboendarterectomy) 01/2022
1	Transcutaneous Electric Nerve Stimulation (TENS) 11/2021
1	Photochemotherapy (Photodynamic Therapy) 09/2021
1	Mechanical Ventilators (Ventilator) 01/2021
1	Continuous Positive Airway Pressure 12/2020
1	Anesthesia 10/2019
1	Tissue and Organ Harvesting 09/2019
1	Cell- and Tissue-Based Therapy (Cell Therapy) 05/2019
1	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2018